Jeanine E. Roeters van Lennep

4 ta ish

Erasmus MC

1. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

   Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens +97

   MaqolaOAOchiq kirish20233 iqtibos

   ABIABI:AkademIndex/2026.other.233436

2. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

   Barbara Sjouke, D. Meeike Kusters, Iris Kindt +10

   MaqolaOAOchiq kirish20142 iqtibos

   ABIABI:AkademIndex/2026.other.011146

3. Adverse Events Associated With <scp>PCSK</scp>9 Inhibitors: A Real‐World Experience

   Muhammed T. Gürgöze, A H G Muller-Hansma, Michelle M. Schreuder +3

   MaqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.245654

4. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

   Marina Cuchel, Frederick J. Raal, Robert A. Hegele +20

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.890201